TrueRepertoire

Celemics, Inc. has developed a NGS-based antibody sequencing platform with the aim to overcome key issues of sequencing error, short-read length and high-cost gene synthesis for further characterization. Celemics’ newly developed platform, TrueRepertoire will allow you to sequence scFv or Fab library, analyze the entire variable region and process over 10,000 clones for a single experiment